Earnings Preview: Biotechnology Looks Healthy – Barron’s

Posted: April 11, 2017 at 3:44 pm


Barron's
Earnings Preview: Biotechnology Looks Healthy
Barron's
The iShares Nasdaq Biotechnology (IBB) has climbed 0.34%. Meanwhile the SPDR S&P Biotech ETF (XBI) has declined 0.21%. IBB could be benefiting from having a wider swath of companies, in addition to the fact that the average market cap of its index ...

and more »

Originally posted here:
Earnings Preview: Biotechnology Looks Healthy - Barron's

Related Posts